Athira Pharma, Inc.
USD6.75
-0.44 (-6.12%)
CEO
Mark J. Litton
IPO Date
2020-09-18
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$7.30
Prev. Close
$7.19
Day Low
$6.61
Day High
$7.35
52W Low
$2.20
52W High
$8.36
Market Cap
$0.03B
Volume
0.07M
| -0.2 |
| 31 Dec 2023 | FY | 0.0% | 0.0% | -90.4% | -73.4% | 0.01 | 5.37 | -0.8 |
| 31 Dec 2022 | FY | 0.0% | 0.0% | -40.7% | -37.0% | 0.01 | 9.68 | -1.3 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | -17.1% | -16.5% | 0.01 | 28.07 | -8.8 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | -7.3% | -7.1% | 0.00 | 43.66 | -55.8 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | 26.2% | -235.8% | -0.08 | 1.70 | -108.1 |
| 31 Dec 2018 | FY | 0.0% | 0.0% | 34.2% | -103.3% | -0.05 | 8.56 | -109.5 |
| -0.1 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | -24.7% | -22.0% | 0.03 | 9.70 | -0.6 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | -21.8% | -19.6% | 0.03 | 10.81 | -0.4 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | -24.5% | -21.0% | 0.03 | 7.26 | -0.3 |
| 31 Dec 2024 | Q4 | 0.0% | 0.0% | -33.5% | -25.5% | 0.03 | 4.18 | -0.4 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | -49.9% | -33.3% | 0.02 | 2.95 | -0.1 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | -32.2% | -24.1% | 0.02 | 3.97 | -0.9 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | -24.7% | -19.7% | 0.01 | 5.03 | -0.9 |
| 31 Dec 2023 | Q4 | 0.0% | 0.0% | -21.0% | -17.0% | 0.01 | 5.37 | -0.8 |